Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Antonio Ramirez de"'
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Hyperkalemia (HK) is frequently present in chronic kidney disease (CKD). Risk factors for HK among CKD patients include comorbidities and renin–angiotensin–aldosterone system inhibitor (RAASi) treatment. Current standard of ca
Externí odkaz:
https://doaj.org/article/8d4d1d3f8b934fc3adf2b91b191b2778
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-15 (2023)
Abstract Background Chronic kidney disease (CKD) patients with and without heart failure (HF) often present with hyperkalaemia (HK) leading to increased risk of hospitalisations, cardiovascular related events and cardiovascular-related mortality. Ren
Externí odkaz:
https://doaj.org/article/ef2bf1a535d040729b10560de1e96fea
Autor:
Gionata Fiorino, Jean-Frederic Colombel, Kostas Katsanos, Fermín Mearin, Jürgen Stein, Margherita Andretta, Stefania Antonacci, Loredana Arenare, Rita Citraro, Stefania Dell’Orco, Luca Degli Esposti, Antonio Ramirez de Arellano Serna, Neige Morin, Ioannis E. Koutroubakis
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: Iron deficiency anemia (IDA) is a common extraintestinal manifestation of inflammatory bowel disease (IBD), affecting around one-third of patients. Objective: To compare IBD progression and healthcare resource utilization in patients with
Externí odkaz:
https://doaj.org/article/5d32fae6e0624211ab73e3055b1d118a
Autor:
Federico Argüelles-Arias, Fernando Bermejo, Joaquín Borrás-Blasco, Eugeni Domènech, Beatriz Sicilia, José M. Huguet, Antonio Ramirez de Arellano, William J. Valentine, Barnaby Hunt
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: Iron deficiency anemia (IDA) is a common complication of inflammatory bowel disease (IBD) and can result in reduced quality of life and increased healthcare costs. IDA is treated with iron supplementation, commonly with intravenous iron f
Externí odkaz:
https://doaj.org/article/9dc02893f99d4ed581fece6ca07a0b62
Autor:
Jesús Mª Nieto Ibáñez, Helena Rodríguez Somolinos, Natalio Fernández Marcos, Javier Uria, Ana González-Rivas, José García López, Francisco Socas, Jose Manuel Cañas Reillo, Antonio Piñero, Francisco R. Adrados, Jose A. Berenguer, Matilde Conde Salazar, Luis M. Macía Aparicio, José B. Torres, Francisca Pordomingo, Dulce Estefania Álvarez, José Antonio Bellido Díaz, Antonio Ramirez de Verger, Guillermo Sven Reher Díez, Dolores Lara Nava, Jorge Martínez-Pinna
Publikováno v:
Emerita, Vol 78, Iss 1, Pp 137-191 (2010)
Externí odkaz:
https://doaj.org/article/8f20f63170d144eb934142f000e44919
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Phil McEwan, Cale Harrison, Rhona Binnie, Ruth D. Lewis, Alain Cohen‐Solal, Lars H. Lund, Marcus Ohlsson, Stephan von Haehling, Josep Comin‐Colet, Domingo A. Pascual‐Figal, Sandra Wächter, Fabio Dorigotti, Antonio Ramirez de Arellano, Piotr Ponikowski, Ewa A. Jankowska
Publikováno v:
European Journal of Heart Failure. 25:389-398
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dda001f6d27b538cfa8b807d55c40c59
https://doi.org/10.1002/ejhf.2788
https://doi.org/10.1002/ejhf.2788
Autor:
Antonio Ramirez de Arellano, Nicholas Norton, Dana Enkusson, Linnea Oldsberg, Yvonne Thomson, Mathias Lilja, Aysegül Aksan
Publikováno v:
GastroHep. 2022:1-10
Aims. A widespread complication of inflammatory bowel disease (IBD) is iron deficiency anaemia (IDA), which affects quality of life (QoL) and is associated with frequent hospitalizations. The intravenous iron therapies, ferric carboxymaltose (FCM), f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df8920dc716f101acb9d839ba042c3bb
https://doi.org/10.1155/2022/9991311
https://doi.org/10.1155/2022/9991311
Autor:
Thomas, Ward, Tray, Brown, Ruth D, Lewis, Melodi Kosaner, Kliess, Antonio Ramirez, de Arellano, Carol M, Quinn
Publikováno v:
PharmacoEconomics - Open. 6:757-771
Hyperkalaemia can be a life-threatening condition, particularly in patients with advanced chronic kidney disease with and without heart failure. Renin-angiotensin-aldosterone system inhibitor therapy offers cardiorenal protection in chronic kidney di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd2f53eabb98d21cb77f6d90c52d6dfe
https://doi.org/10.1007/s41669-022-00357-z
https://doi.org/10.1007/s41669-022-00357-z